Skip to main content
. Author manuscript; available in PMC: 2014 Jun 12.
Published in final edited form as: J Gastrointest Surg. 2008 Jul 19;12(12):2171–2176. doi: 10.1007/s11605-008-0584-x

Table 3.

Overall Survival in Node-Negative Patients with Strong vs. Weak or No Expression of miR-21

miR-21 Median (months) 1 year (%) 5 year (%)
0–1+ 27.7 72 16
2+ 15.2 57.1 0